Form 4: Mega Acquires Boston Scientific Stock

Jessica L. Mega, a Director at Boston Scientific Corp., acquired 3,800 shares of common stock on May 7, 2026, as part of an annual equity award.

Summary

• Jessica L. Mega, a Director of Boston Scientific Corp. (BSX), acquired 3,800 shares of common stock on May 7, 2026.
• This acquisition was part of an annual equity award valued at $215,000, based on the closing price of the common stock on the grant date.
• Following this transaction, Mega beneficially owns 12,035 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, representing a standard insider equity award rather than a significant strategic or financial event.

Positives

• Director Jessica L. Mega received an annual equity award, indicating continued alignment of management and director interests with shareholders.
• The award is structured as restricted stock vesting upon the next annual meeting of stockholders, incentivizing long-term performance.

Future Outlook

The restricted stock award vests in full upon the next annual meeting of stockholders, suggesting a forward-looking incentive tied to company performance and governance.

Industry Context

StockSavvy.ai notes that insider equity awards are common in the medical device industry as a tool for executive and director compensation and retention, aligning their interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The equity award aligns director compensation with shareholder interests, potentially fostering long-term value creation.

Next Steps

• Restricted stock vests upon the next annual meeting of stockholders.

Key Dates

Keywords

Boston Scientific Corp, BSX, Form 4, Insider Transaction, Equity Award, Restricted Stock, Director Compensation